Tortoise Investment Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
21,676
| – | – | ﹤0.01% | 566 |
|
|
2025
Q1 | $5.85K | Hold |
21,676
| – | – | ﹤0.01% | 619 |
|
|
2024
Q4 | $11.3K | Hold |
21,676
| – | – | ﹤0.01% | 613 |
|
|
2024
Q3 | $70.2K | Hold |
21,676
| – | – | 0.01% | 361 |
|
|
2024
Q2 | $65K | Hold |
21,676
| – | – | 0.01% | 356 |
|
|
2024
Q1 | $101K | Hold |
21,676
| – | – | 0.01% | 294 |
|
|
2023
Q4 | $89.7K | Hold |
21,676
| – | – | 0.01% | 291 |
|
|
2023
Q3 | $65K | Buy |
21,676
+2,500
| +13% | +$7.5K | 0.01% | 312 |
|
|
2023
Q2 | $47.2K | Buy |
19,176
+6,615
| +53% | +$16.3K | 0.01% | 354 |
|
|
2023
Q1 | $28.4K | Buy |
12,561
+4,976
| +66% | +$11.2K | ﹤0.01% | 409 |
|
|
2022
Q4 | $26.5K | Buy |
7,585
+2,300
| +44% | +$8.03K | ﹤0.01% | 410 |
|
|
2022
Q3 | $196K | Sell |
5,285
-796
| -13% | -$29.5K | 0.04% | 184 |
|
|
2022
Q2 | $115K | Hold |
6,081
| – | – | 0.02% | 214 |
|
|
2022
Q1 | $164K | Sell |
6,081
-600
| -9% | -$16.2K | 0.03% | 193 |
|
|
2021
Q4 | $151K | Buy |
6,681
+1,150
| +21% | +$26K | 0.03% | 187 |
|
|
2021
Q3 | $145K | Buy |
5,531
+1,196
| +28% | +$31.4K | 0.03% | 183 |
|
|
2021
Q2 | $139K | Hold |
4,335
| – | – | 0.03% | 181 |
|
|
2021
Q1 | $153K | Hold |
4,335
| – | – | 0.03% | 170 |
|
|
2020
Q4 | $139K | Buy |
4,335
+500
| +13% | +$16K | 0.03% | 169 |
|
|
2020
Q3 | $144K | Hold |
3,835
| – | – | 0.04% | 157 |
|
|
2020
Q2 | $172K | Hold |
3,835
| – | – | 0.04% | 145 |
|
|
2020
Q1 | $131K | Buy |
3,835
+935
| +32% | +$31.9K | 0.04% | 152 |
|
|
2019
Q4 | $113K | Buy |
+2,900
| New | +$113K | 0.03% | 180 |
|